M. Pecht et al., POTENTIATION OF MYELOID COLONY-FORMATION IN BONE-MARROW OF INTACT ANDNEONATALLY THYMECTOMIZED MICE BY THE THYMIC HORMONE THF-GAMMA-2, Experimental hematology, 21(2), 1993, pp. 277-282
The effect of the thymic hormone THF-gamma 2 on committed stem cells o
f bone marrow (BM) origin was determined using the myeloid progenitor
cell clonal assay. Preincubation of normal BM cells with THF-gamma 2 f
or 1 hour or 18 hours caused a 2- to 6-fold increase in the number of
myeloid colonies in the presence of suboptimal concentrations of colon
y-stimulating factor (CSF). The optimal dose of THF-gamma 2 causing th
is enhancement was in the range of 25 to 100 ng/mL. THF-gamma 2 was no
t able to replace CSF as an inducer in these experiments. THF-gamma 2
neither induced IL-6 activity upon 24-hour incubation with bone marrow
cells nor enhanced LPS-induced IL-6 secretion by bone marrow cells in
vitro. Neonatal thymectomy (NTx) of Balb/c mice caused a decrease in
myeloid progenitors, which was repaired by serial injections of THF-ga
mma 2. The repair of the stem cell compartment in the bone marrow corr
elated with an increased percentage of Thy1(+) cells in the spleen of
THF-gamma 2-treated NTx mice. These findings indicate that THF-gamma 2
is able to regulate committed stem cell functions in the bone marrow
of immune-deprived NTx and of normal mice.